DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $910,460 | -17.0% | 3,670 | -19.7% | 0.46% | -7.2% |
| Q2 2023 | $1,097,237 | -8.9% | 4,572 | -4.3% | 0.50% | -33.5% |
| Q1 2023 | $1,204,567 | -7.4% | 4,779 | -2.4% | 0.75% | -5.2% |
| Q4 2022 | $1,300,176 | -14.0% | 4,899 | -16.2% | 0.79% | -21.8% |
| Q3 2022 | $1,511,000 | -1.0% | 5,849 | -2.9% | 1.02% | +6.5% |
| Q2 2022 | $1,527,000 | -30.5% | 6,023 | -19.6% | 0.95% | -5.6% |
| Q1 2022 | $2,197,000 | -23.3% | 7,491 | -13.9% | 1.01% | -16.0% |
| Q4 2021 | $2,863,000 | +16.4% | 8,701 | +7.7% | 1.20% | -0.1% |
| Q3 2021 | $2,459,000 | +189.0% | 8,078 | +154.7% | 1.20% | +189.6% |
| Q2 2021 | $851,000 | +15.9% | 3,172 | -2.7% | 0.42% | -1.7% |
| Q1 2021 | $734,000 | +24.6% | 3,260 | +23.0% | 0.42% | +23.0% |
| Q4 2020 | $589,000 | +8.1% | 2,650 | +4.7% | 0.34% | -8.5% |
| Q3 2020 | $545,000 | +43.0% | 2,532 | +17.4% | 0.38% | +19.8% |
| Q2 2020 | $381,000 | +86.8% | 2,156 | +62.5% | 0.31% | +122.0% |
| Q4 2019 | $204,000 | – | 1,327 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |